Sunday, 25 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

Wyze Biotech Raises RMB59m to Advance DNT Cell Therapies

February 15, 2025
CompanyDrug

Sanjin Pharma’s Subsidiary Gets NMPA Nod for BC007 Cancer Study

February 15, 2025
CompanyDrug

I-Mab and AbbVie End CD47 Antibody Trial but Continue Collaboration

February 15, 2025
CompanyDeals

Menovo Pharmaceutical Plans RMB892m Private Placement to Boost API Production

February 15, 2025
CompanyDeals

BeiGene Partners with Ontada to Accelerate RWE Development in US Oncology Market

February 15, 2025
CompanyDrug

Grand Pharmaceutical’s Carglumic Acid Set for Priority Review by CDE

February 15, 2025
CompanyDrug

Ascletis Pharma’s Gannex Initiates DDI Study for ASC42 in PBC

February 15, 2025
CompanyMedical Device

Venus Medtech’s VenusP-Valve Used Again in US Compassionate Case

February 15, 2025
Drug

Luye Pharma’s Goserelin Acetate Injectable Accepted for Breast Cancer Review

February 15, 2025
CompanyDeals

Healthnice Pharma Raises RMB100m to Expand Product Pipeline and R&D Team

February 15, 2025
CompanyDeals

Healthnice Pharma Raises RMB100m to Expand Product Pipeline and R&D Team

February 15, 2025
CompanyDeals

Gilead Transfers Trodelvy Asian Rights to Everest Medicines for USD280m

February 15, 2025
1 2 … 9 10 11 12 13 … 21 22
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up